37th Annual Meeting of the Society for Medical Decision Making

October 18 - 21, 2015

Mark Harrison, PhD

Faculty of Pharmaceutical Sciences, University of British Columbia
University of British Columbia
Vancouver, BC
Canada V6T 1Z3

Papers:
AVERSION TO AMBIGUITY ABOUT THE RISK OF TREATMENT HARMS INFLUENCES DECISION MAKING AND VARIES BY LEVEL OF RISK AND AMBIGUITY WHAT IS THE IMPACT OF DESCRIBING TREATMENTS AS 'NEW'?